147 related articles for article (PubMed ID: 38469294)
1. Utilizing murine dendritic cell line DC2.4 to evaluate the immunogenicity of subunit vaccines
Lu L; Kong WY; Zhang J; Firdaus F; Wells JW; Stephenson RJ; Toth I; Skwarczynski M; Cruz JLG
Front Immunol; 2024; 15():1298721. PubMed ID: 38469294
[TBL] [Abstract][Full Text] [Related]
2. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.
Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A
Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812
[TBL] [Abstract][Full Text] [Related]
3. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
He T; Tang C; Xu S; Moyana T; Xiang J
Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
[TBL] [Abstract][Full Text] [Related]
4. Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity.
Kalady MF; Onaitis MW; Emani S; Abdel-Wahab Z; Tyler DS; Pruitt SK
J Surg Res; 2004 Jan; 116(1):24-31. PubMed ID: 14732346
[TBL] [Abstract][Full Text] [Related]
5. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
6. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation.
Fujii S; Liu K; Smith C; Bonito AJ; Steinman RM
J Exp Med; 2004 Jun; 199(12):1607-18. PubMed ID: 15197224
[TBL] [Abstract][Full Text] [Related]
7. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
[TBL] [Abstract][Full Text] [Related]
8. The Improved Antigen Uptake and Presentation of Dendritic Cells Using Cell-Penetrating D-octaarginine-Linked PNVA-co-AA as a Novel Dendritic Cell-Based Vaccine.
Fujioka Y; Ueki H; A R; Sasajima A; Tomono T; Ukawa M; Yagi H; Sakuma S; Kitagawa K; Shirakawa T
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892182
[TBL] [Abstract][Full Text] [Related]
9. Chemokine programming dendritic cell antigen response: part II - programming antigen presentation to T lymphocytes by partially maintaining immature dendritic cell phenotype.
Park J; Bryers JD
Immunology; 2013 May; 139(1):88-99. PubMed ID: 23277917
[TBL] [Abstract][Full Text] [Related]
10. Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant.
Engel AL; Sun GC; Gad E; Rastetter LR; Strobe K; Yang Y; Dang Y; Disis ML; Lu H
Immunobiology; 2013 Dec; 218(12):1468-76. PubMed ID: 23735481
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation.
Steinman RM
Mt Sinai J Med; 2001 May; 68(3):160-6. PubMed ID: 11373688
[TBL] [Abstract][Full Text] [Related]
12. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
[TBL] [Abstract][Full Text] [Related]
13. Lactoferrin modulation of BCG-infected dendritic cell functions.
Hwang SA; Actor JK
Int Immunol; 2009 Oct; 21(10):1185-97. PubMed ID: 19692539
[TBL] [Abstract][Full Text] [Related]
14. Enhanced protective immunity derived from dendritic cells with phagocytosis of CD40 ligand transgene-engineered apoptotic tumor cells via increased dendritic cell maturation.
Parameswaran S; Khalil M; Ahmed KA; Sharma RK; Xiang J
Tumori; 2015; 101(6):637-43. PubMed ID: 25983089
[TBL] [Abstract][Full Text] [Related]
15. Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells.
Yin W; Gorvel L; Zurawski S; Li D; Ni L; Duluc D; Upchurch K; Kim J; Gu C; Ouedraogo R; Wang Z; Xue Y; Joo H; Gorvel JP; Zurawski G; Oh S
EBioMedicine; 2016 Mar; 5():46-58. PubMed ID: 27077111
[TBL] [Abstract][Full Text] [Related]
16. Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines.
Yoshimura S; Bondeson J; Foxwell BM; Brennan FM; Feldmann M
Int Immunol; 2001 May; 13(5):675-83. PubMed ID: 11312255
[TBL] [Abstract][Full Text] [Related]
17. Combined TLR-3/TLR-8 Signaling in the Presence of α-Type-1 Cytokines Represents a Novel and Potent Dendritic Cell Type-1, Anti-Cancer Maturation Protocol.
Fevžer T; Poženel P; Zajc K; Tešić N; Švajger U
Cells; 2022 Feb; 11(5):. PubMed ID: 35269457
[TBL] [Abstract][Full Text] [Related]
18. The role of the 47-kDa membrane lipoprotein of Treponema pallidum in promoting maturation of peripheral blood monocyte-derived dendritic cells without enhancing C-C chemokine receptor type 7-mediated dendritic cell migration.
Cheng W; Lu Y; Chen R; Ren H; Hu W
Adv Clin Exp Med; 2023 Mar; 32(3):369-377. PubMed ID: 36330841
[TBL] [Abstract][Full Text] [Related]
19.
Letendre C; Auger JP; Lemire P; Galbas T; Gottschalk M; Thibodeau J; Segura M
Front Immunol; 2018; 9():1199. PubMed ID: 29899744
[No Abstract] [Full Text] [Related]
20. Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes.
Melief CJ; Van Der Burg SH; Toes RE; Ossendorp F; Offringa R
Immunol Rev; 2002 Oct; 188():177-82. PubMed ID: 12445291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
